Follow
Michael Miller, MD
Michael Miller, MD
Professor of Medicine, Hospital of the University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Title
Cited by
Cited by
Year
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
cannon cp
6555*2004
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ...
New England Journal of Medicine 380 (1), 11-22, 2019
27922019
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association
M Miller, NJ Stone, C Ballantyne, V Bittner, MH Criqui, HN Ginsberg, ...
Circulation 123 (20), 2292-2333, 2011
22972011
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
FM Sacks, AH Lichtenstein, JHY Wu, LJ Appel, MA Creager, ...
Circulation 136 (3), e1-e23, 2017
14302017
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events
B Pitt, RP Byington, CD Furberg, DB Hunninghake, GBJ Mancini, ...
Circulation 102 (13), 1503-1510, 2000
12532000
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives
WS Harris, M Miller, AP Tighe, MH Davidson, EJ Schaefer
Atherosclerosis 197 (1), 12-24, 2008
8612008
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection
TI Pollin, CM Damcott, H Shen, SH Ott, J Shelton, RB Horenstein, W Post, ...
Science 322 (5908), 1702-1705, 2008
8402008
Extended-release niacin or ezetimibe and carotid intima–media thickness
AJ Taylor, TC Villines, EJ Stanek, PJ Devine, L Griffen, M Miller, ...
New England Journal of Medicine 361 (22), 2113-2122, 2009
8302009
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
M Miller, CP Cannon, SA Murphy, J Qin, KK Ray, E Braunwald, ...
Journal of the American College of Cardiology 51 (7), 724-730, 2008
8142008
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
C Reactive Protein Coronary Heart Disease Genetics Collaboration
Bmj 342, 2011
6632011
Cardiovascular efficacy and safety of bococizumab in high-risk patients
PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ...
New England Journal of Medicine 376 (16), 1527-1539, 2017
6492017
Statin safety and associated adverse events: a scientific statement from the American Heart Association
CB Newman, D Preiss, JA Tobert, TA Jacobson, RL Page, LB Goldstein, ...
Arteriosclerosis, thrombosis, and vascular biology 39 (2), e38-e81, 2019
5712019
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
4842019
Driver fusions and their implications in the development and treatment of human cancers
Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ...
Cell reports 23 (1), 227-238. e3, 2018
4702018
Comparative molecular analysis of gastrointestinal adenocarcinomas
Y Liu, NS Sethi, T Hinoue, BG Schneider, AD Cherniack, F Sanchez-Vega, ...
Cancer cell 33 (4), 721-735. e8, 2018
4692018
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina
E Topol, R Califf, F Van de Werf, R Diaz, E Paolasso, P Aylward, J Simes, ...
Circulation 97 (24), 2386-2395, 1998
4311998
Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association
AC Skulas-Ray, PWF Wilson, WS Harris, EA Brinton, PM Kris-Etherton, ...
Circulation 140 (12), e673-e691, 2019
3832019
Characterization of myocardial injury in patients with COVID-19
G Giustino, LB Croft, GG Stefanini, R Bragato, JJ Silbiger, M Vicenzi, ...
Journal of the American College of Cardiology 76 (18), 2043-2055, 2020
3812020
Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types
M Seiler, S Peng, AA Agrawal, J Palacino, T Teng, P Zhu, PG Smith, ...
Cell reports 23 (1), 282-296. e4, 2018
3752018
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study
J Shepherd, JJP Kastelein, V Bittner, P Deedwania, A Breazna, S Dobson, ...
Clinical Journal of the American Society of Nephrology 2 (6), 1131-1139, 2007
3702007
The system can't perform the operation now. Try again later.
Articles 1–20